Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GUCA2A,Guanylin,Wald ratio,1,1.18 [1.06-1.32],0.00203144829837292,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RSPO1,R-spondin-1,Wald ratio,1,0.86 [0.77-0.96],0.0053080603867559,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL1R1,Interleukin-1 receptor type 1,Wald ratio,1,1.15 [1.04-1.29],0.00852860512961062,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,QPCT,Glutaminyl-peptide cyclotransferase,Wald ratio,1,0.86 [0.78-0.96],0.00877069115019073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Wald ratio,1,0.88 [0.8-0.98],0.0226144384334753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Wald ratio,1,0.9 [0.82-0.99],0.0315888872957694,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TCN2,Transcobalamin-2,Wald ratio,1,1.1 [1-1.2],0.0398394119350382,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NFASC,Neurofascin,Wald ratio,1,1.11 [1-1.22],0.0443879678948021,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RBFOX3,RNA binding protein fox-1 homolog 3,Wald ratio,1,1.11 [1-1.22],0.0456316789268204,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TIMP1,Metalloproteinase inhibitor 1,Wald ratio,1,0.9 [0.81-1],0.0468640908277573,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CKAP4,Cytoskeleton-associated protein 4,Wald ratio,1,0.9 [0.81-1],0.0505729554906947,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,0.9 [0.81-1],0.0597090202010073,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SEPTIN8,Septin-8,Wald ratio,1,1.11 [1-1.23],0.061038230778755,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CCL14,C-C motif chemokine 14,Wald ratio,1,0.91 [0.82-1.01],0.0743992604172983,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FSTL1,Follistatin-related protein 1,Wald ratio,1,0.91 [0.82-1.02],0.0982496260971946,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SFRP1,Secreted frizzled-related protein 1,Wald ratio,1,0.92 [0.83-1.02],0.101643191621778,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,0.91 [0.82-1.02],0.103602091193852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SPINK4,Serine protease inhibitor Kazal-type 4,Wald ratio,1,1.07 [0.98-1.17],0.10766005440465,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,1.09 [0.98-1.2],0.119344551411698,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,INHBB,Inhibin beta B chain,Wald ratio,1,0.92 [0.83-1.02],0.119659086420582,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CHRDL1,Chordin-like protein 1,Wald ratio,1,0.93 [0.84-1.02],0.125625933691039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SEMA7A,Semaphorin-7A,Wald ratio,1,1.09 [0.98-1.21],0.128800122463258,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Wald ratio,1,0.93 [0.84-1.02],0.128905619653427,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VASN,Vasorin,Wald ratio,1,0.92 [0.83-1.02],0.130452586204001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GPNMB,Transmembrane glycoprotein NMB,Wald ratio,1,0.92 [0.83-1.02],0.132532424795719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CRIM1,Cysteine-rich motor neuron 1 protein,Wald ratio,1,0.92 [0.83-1.03],0.133679934282776,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,REG4,Regenerating islet-derived protein 4,Wald ratio,1,1.08 [0.97-1.2],0.139140796734522,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CSF1,Macrophage colony-stimulating factor 1,Wald ratio,1,0.92 [0.83-1.03],0.14872626537829,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CCN4,CCN family member 4,Wald ratio,1,0.93 [0.84-1.03],0.14879218424484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,COL18A1,Collagen alpha-1(XVIII) chain,Wald ratio,1,0.93 [0.84-1.03],0.15126126601685,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.93 [0.84-1.03],0.164552939492361,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD274,Programmed cell death 1 ligand 1,Wald ratio,1,0.93 [0.84-1.03],0.166402596819391,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FOLR1,Folate receptor alpha,Wald ratio,1,1.08 [0.97-1.19],0.16829168448488,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LAG3,Lymphocyte activation gene 3 protein,Wald ratio,1,1.08 [0.97-1.19],0.170671962306433,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PGF,Placenta growth factor,Wald ratio,1,0.94 [0.85-1.03],0.176461932401351,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.08 [0.97-1.2],0.1814340163359,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TGOLN2,Trans-Golgi network integral membrane protein 2,Wald ratio,1,0.93 [0.83-1.04],0.181835166787113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VEGFD,Vascular endothelial growth factor D,Wald ratio,1,1.08 [0.97-1.2],0.184266526448211,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CLEC5A,C-type lectin domain family 5 member A,Wald ratio,1,0.93 [0.84-1.03],0.189616413665298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SMOC2,SPARC-related modular calcium-binding protein 2,Wald ratio,1,0.94 [0.85-1.03],0.193312283011224,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD5,T-cell surface glycoprotein CD5,Wald ratio,1,1.07 [0.96-1.19],0.196780796852811,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CDH3,Cadherin-3,Wald ratio,1,0.93 [0.84-1.04],0.217197910763447,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,B4GALT1,"Beta-1,4-galactosyltransferase 1",Wald ratio,1,0.94 [0.84-1.04],0.223790640765166,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LTBR,Tumor necrosis factor receptor superfamily member 3,Wald ratio,1,0.94 [0.84-1.04],0.226430412121145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADGRD1,Adhesion G-protein coupled receptor D1,Wald ratio,1,1.06 [0.96-1.16],0.233318390186777,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.94 [0.84-1.04],0.238348705587763,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CST3,Cystatin-C,Wald ratio,1,0.94 [0.85-1.04],0.241042288746635,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SCGN,Secretagogin,Wald ratio,1,1.07 [0.96-1.19],0.244509948937759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PALM2,Paralemmin-2,Wald ratio,1,0.94 [0.85-1.05],0.268292689062614,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,AOC3,Membrane primary amine oxidase,Wald ratio,1,1.05 [0.96-1.16],0.279950775687735,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Wald ratio,1,0.95 [0.87-1.04],0.284923331327596,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Wald ratio,1,1.05 [0.96-1.16],0.286701497942514,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SLC39A14,Zinc transporter ZIP14,Wald ratio,1,0.94 [0.84-1.05],0.293579566104237,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NELL1,Protein kinase C-binding protein NELL1,Wald ratio,1,1.06 [0.95-1.17],0.296259605506206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SIRPB1,Signal-regulatory protein beta-1,Wald ratio,1,0.96 [0.88-1.04],0.303862331466702,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FGF23,Fibroblast growth factor 23,Wald ratio,1,1.06 [0.95-1.18],0.303872252468672,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SPON2,Spondin-2,Wald ratio,1,0.95 [0.85-1.05],0.307242455613971,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RSPO3,R-spondin-3,Wald ratio,1,0.95 [0.86-1.05],0.309052865608072,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD46,Membrane cofactor protein,Wald ratio,1,0.95 [0.85-1.05],0.30995564186521,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD300C,CMRF35-like molecule 6,Wald ratio,1,0.95 [0.86-1.05],0.31859543308561,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PLXNB2,Plexin-B2,Wald ratio,1,1.05 [0.96-1.15],0.32055514789394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TAFA5,Chemokine-like protein TAFA-5,Wald ratio,1,0.95 [0.85-1.05],0.326227959499285,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VWC2,Brorin,Wald ratio,1,0.95 [0.86-1.05],0.328607823125683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CCL15,C-C motif chemokine 15,Wald ratio,1,0.96 [0.87-1.05],0.32918681303558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Wald ratio,1,1.05 [0.95-1.15],0.329408294975908,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD276,CD276 antigen,Wald ratio,1,0.96 [0.87-1.05],0.330994196940034,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LGALS4,Galectin-4,Wald ratio,1,1.05 [0.95-1.16],0.338670582729844,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.05 [0.95-1.17],0.343453146850298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD99,CD99 antigen,Wald ratio,1,1.05 [0.95-1.15],0.347954854448061,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BTN3A2,Butyrophilin subfamily 3 member A2,Wald ratio,1,1.05 [0.95-1.15],0.363795868426867,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ULBP2,UL16-binding protein 2,Wald ratio,1,1.05 [0.95-1.16],0.367016382505394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADGRE2,Adhesion G protein-coupled receptor E2,Wald ratio,1,0.95 [0.86-1.06],0.375933495149209,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PLAUR,Urokinase plasminogen activator surface receptor,Wald ratio,1,0.95 [0.86-1.06],0.389778811912944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Wald ratio,1,1.05 [0.94-1.17],0.390745936499246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,COLEC12,Collectin-12,Wald ratio,1,0.96 [0.87-1.06],0.390870779420905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BCAM,Basal cell adhesion molecule,Wald ratio,1,1.05 [0.94-1.16],0.392371643661587,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NCS1,Neuronal calcium sensor 1,Wald ratio,1,1.04 [0.95-1.15],0.392451660072944,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CHGB,Secretogranin-1,Wald ratio,1,0.96 [0.87-1.06],0.394512381547616,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NECTIN2,Nectin-2,Wald ratio,1,0.95 [0.86-1.06],0.397955508964423,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CDNF,Cerebral dopamine neurotrophic factor,Wald ratio,1,1.05 [0.94-1.16],0.398096815727972,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD93,Complement component C1q receptor,Wald ratio,1,1.05 [0.94-1.17],0.399176490716943,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Wald ratio,1,0.96 [0.86-1.06],0.400207868311474,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Wald ratio,1,1.05 [0.94-1.16],0.407477574871815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DKK3,Dickkopf-related protein 3,Wald ratio,1,0.96 [0.87-1.06],0.410445734109579,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HAVCR1,Hepatitis A virus cellular receptor 1,Wald ratio,1,1.04 [0.95-1.13],0.411196919979219,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PDCD1LG2,Programmed cell death 1 ligand 2,Wald ratio,1,1.04 [0.95-1.13],0.412258898737096,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,C7,Complement component C7,Wald ratio,1,0.96 [0.87-1.06],0.417337150389446,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD83,CD83 antigen,Wald ratio,1,1.04 [0.94-1.16],0.421904419063656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.04 [0.94-1.15],0.423293950237395,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DLL1,Delta-like protein 1,Wald ratio,1,0.96 [0.86-1.06],0.423398942774818,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RELT,Tumor necrosis factor receptor superfamily member 19L,Wald ratio,1,0.96 [0.87-1.06],0.424728188488989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CHI3L1,Chitinase-3-like protein 1,Wald ratio,1,1.04 [0.94-1.14],0.42558407474046,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.04 [0.94-1.16],0.426501879142942,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DDR1,Epithelial discoidin domain-containing receptor 1,Wald ratio,1,1.04 [0.94-1.15],0.426771921400176,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Wald ratio,1,0.96 [0.87-1.06],0.435529618163982,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DSG2,Desmoglein-2,Wald ratio,1,0.96 [0.87-1.06],0.439209226837915,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NPPB,Natriuretic peptides B,Wald ratio,1,0.96 [0.86-1.07],0.44274159139039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RNASET2,Ribonuclease T2,Wald ratio,1,0.96 [0.87-1.06],0.449884708123286,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DKK4,Dickkopf-related protein 4,Wald ratio,1,1.04 [0.94-1.16],0.451378933212135,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Wald ratio,1,1.04 [0.94-1.15],0.45457153288143,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Wald ratio,1,0.96 [0.87-1.06],0.455305494011553,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD4,T-cell surface glycoprotein CD4,Wald ratio,1,0.96 [0.86-1.07],0.459535353098055,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Wald ratio,1,1.04 [0.94-1.15],0.459553039620289,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RNF149,E3 ubiquitin-protein ligase RNF149,Wald ratio,1,0.96 [0.86-1.07],0.462877699589959,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CGREF1,Cell growth regulator with EF hand domain protein 1,Wald ratio,1,0.96 [0.86-1.07],0.466785267764802,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PI3,Elafin,Wald ratio,1,0.96 [0.87-1.07],0.468342617865958,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Wald ratio,1,0.96 [0.88-1.06],0.469155777422484,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADGRB3,Adhesion G protein-coupled receptor B3,Wald ratio,1,0.97 [0.9-1.05],0.472430329576785,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FGL1,Fibrinogen-like protein 1,Wald ratio,1,0.97 [0.89-1.06],0.478718476606381,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Wald ratio,1,1.04 [0.94-1.15],0.478976512792206,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CCN5,CCN family member 5,Wald ratio,1,0.97 [0.88-1.06],0.480840017317231,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BAMBI,BMP and activin membrane-bound inhibitor homolog,Wald ratio,1,0.96 [0.86-1.07],0.498746708971323,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,COL4A1,Collagen alpha-1(IV) chain,Wald ratio,1,0.96 [0.87-1.07],0.500795717108049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Wald ratio,1,0.97 [0.87-1.07],0.501379434585039,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Wald ratio,1,0.97 [0.87-1.07],0.50653915325449,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SPINK1,Serine protease inhibitor Kazal-type 1,Wald ratio,1,1.04 [0.93-1.15],0.506812698968218,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,REN,Renin,Wald ratio,1,0.97 [0.87-1.07],0.511162411307132,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PDGFRA,Platelet-derived growth factor receptor alpha,Wald ratio,1,0.97 [0.87-1.07],0.51548968417505,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,0.97 [0.87-1.07],0.515720399162185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,AGRN,Agrin,Wald ratio,1,1.03 [0.93-1.15],0.516422468089078,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.97 [0.87-1.07],0.518856703951145,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BSG,Basigin,Wald ratio,1,1.04 [0.93-1.15],0.521264727685737,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SLITRK2,SLIT and NTRK-like protein 2,Wald ratio,1,0.97 [0.87-1.07],0.523025062283122,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FAM3B,Protein FAM3B,Wald ratio,1,1.03 [0.94-1.14],0.523902338629767,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,REG3A,Regenerating islet-derived protein 3-alpha,Wald ratio,1,1.03 [0.93-1.15],0.523933848163342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CCN3,CCN family member 3,Wald ratio,1,0.97 [0.88-1.07],0.525243196936933,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VSIG4,V-set and immunoglobulin domain-containing protein 4,Wald ratio,1,0.97 [0.87-1.07],0.528347021279189,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Wald ratio,1,1.04 [0.93-1.15],0.529309185695411,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADGRE5,Adhesion G protein-coupled receptor E5,Wald ratio,1,0.97 [0.87-1.07],0.537642827884001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SCG2,Secretogranin-2,Wald ratio,1,0.97 [0.87-1.08],0.541509908056798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GPR37,Prosaposin receptor GPR37,Wald ratio,1,1.03 [0.94-1.13],0.548171160877283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DCN,Decorin,Wald ratio,1,0.97 [0.87-1.08],0.550832539639657,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ASGR2,Asialoglycoprotein receptor 2,Wald ratio,1,0.97 [0.87-1.08],0.551124424825913,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,STC1,Stanniocalcin-1,Wald ratio,1,0.97 [0.87-1.08],0.551271450819252,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EPHB6,Ephrin type-B receptor 6,Wald ratio,1,0.97 [0.87-1.08],0.551272353701478,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NECTIN4,Nectin-4,Wald ratio,1,1.03 [0.93-1.15],0.551483256120086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TFF3,Trefoil factor 3,Wald ratio,1,0.97 [0.87-1.08],0.556949126739168,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TGFBR3,Transforming growth factor beta receptor type 3,Wald ratio,1,0.97 [0.87-1.08],0.558819677666787,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.97 [0.87-1.08],0.559327987819005,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD200,OX-2 membrane glycoprotein,Wald ratio,1,0.97 [0.87-1.08],0.564157683808118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RGMB,RGM domain family member B,Wald ratio,1,0.97 [0.87-1.08],0.571487335003603,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,B2M,Beta-2-microglobulin,Wald ratio,1,1.03 [0.93-1.14],0.574790971801302,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PRSS8,Prostasin,Wald ratio,1,1.03 [0.93-1.14],0.576370698462823,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SPON1,Spondin-1,Wald ratio,1,0.97 [0.88-1.07],0.580314295223782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RNASE1,Ribonuclease pancreatic,Wald ratio,1,0.97 [0.88-1.08],0.582775199329609,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NCR1,Natural cytotoxicity triggering receptor 1,Wald ratio,1,0.97 [0.87-1.08],0.58556962183257,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EDA2R,Tumor necrosis factor receptor superfamily member 27,Wald ratio,1,0.98 [0.9-1.06],0.587450423781497,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TACSTD2,Tumor-associated calcium signal transducer 2,Wald ratio,1,1.03 [0.93-1.13],0.58873431248667,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP2,Insulin-like growth factor-binding protein 2,Wald ratio,1,0.97 [0.87-1.08],0.589155642086246,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IFNGR1,Interferon gamma receptor 1,Wald ratio,1,0.97 [0.87-1.08],0.590348160200756,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PSAP,Prosaposin,Wald ratio,1,0.97 [0.88-1.08],0.594152036840347,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,REG1B,Lithostathine-1-beta,Wald ratio,1,1.03 [0.93-1.14],0.598464325906081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GGT5,Glutathione hydrolase 5 proenzyme,Wald ratio,1,1.03 [0.92-1.14],0.604478393450179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NOTCH1,Neurogenic locus notch homolog protein 1,Wald ratio,1,0.97 [0.87-1.08],0.605830021236506,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CKB,Creatine kinase B-type,Wald ratio,1,0.97 [0.87-1.08],0.607949688395283,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MANSC1,MANSC domain-containing protein 1,Wald ratio,1,0.97 [0.87-1.08],0.608479085935464,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Wald ratio,1,1.03 [0.93-1.14],0.608918928221568,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD300LG,CMRF35-like molecule 9,Wald ratio,1,0.97 [0.88-1.08],0.611781806688517,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL4R,Interleukin-4 receptor subunit alpha,Wald ratio,1,0.97 [0.88-1.08],0.613204995388377,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,COL6A3,Collagen alpha-3(VI) chain,Wald ratio,1,0.97 [0.88-1.08],0.615550993092458,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL10RB,Interleukin-10 receptor subunit beta,Wald ratio,1,0.98 [0.88-1.08],0.616460011620133,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Wald ratio,1,1.03 [0.93-1.13],0.618379134546558,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.98 [0.9-1.07],0.622507229918141,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PTGDS,Prostaglandin-H2 D-isomerase,Wald ratio,1,1.03 [0.93-1.14],0.625765287542639,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FAM3C,Protein FAM3C,Wald ratio,1,0.97 [0.88-1.08],0.628723958425402,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SNCG,Gamma-synuclein,Wald ratio,1,0.98 [0.9-1.07],0.629641411868647,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,WNT9A,Protein Wnt-9a,Wald ratio,1,0.98 [0.88-1.08],0.631458258863988,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,0.97 [0.87-1.08],0.631776873662772,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Wald ratio,1,1.03 [0.92-1.14],0.638522195157854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Wald ratio,1,0.98 [0.88-1.08],0.639414304378266,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL6ST,Interleukin-6 receptor subunit beta,Wald ratio,1,0.98 [0.88-1.08],0.650746682498974,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ESAM,Endothelial cell-selective adhesion molecule,Wald ratio,1,0.98 [0.88-1.09],0.654646560983443,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP7,Insulin-like growth factor-binding protein 7,Wald ratio,1,1.02 [0.93-1.13],0.656839592643187,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Wald ratio,1,0.98 [0.89-1.08],0.657619290286665,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Wald ratio,1,1.02 [0.92-1.14],0.662021196735753,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,UMOD,Uromodulin,Wald ratio,1,1.02 [0.94-1.11],0.663713766583217,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,AREG,Amphiregulin,Wald ratio,1,0.98 [0.88-1.09],0.665585931316154,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL2RA,Interleukin-2 receptor subunit alpha,Wald ratio,1,1.02 [0.93-1.13],0.666385312921074,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MERTK,Tyrosine-protein kinase Mer,Wald ratio,1,0.98 [0.88-1.08],0.666788241517463,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Wald ratio,1,0.98 [0.9-1.07],0.683822400262299,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CDH1,Cadherin-1,Wald ratio,1,0.98 [0.88-1.09],0.688972371480977,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ELN,Elastin,Wald ratio,1,0.98 [0.91-1.07],0.699037482292475,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADGRG1,Adhesion G-protein coupled receptor G1,Wald ratio,1,1.02 [0.92-1.13],0.699791299926188,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD300E,CMRF35-like molecule 2,Wald ratio,1,0.98 [0.89-1.08],0.700153802417741,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD55,Complement decay-accelerating factor,Wald ratio,1,0.98 [0.88-1.09],0.701573913861656,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.02 [0.92-1.13],0.708232758168681,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EPHA2,Ephrin type-A receptor 2,Wald ratio,1,0.98 [0.88-1.09],0.720605724670197,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,RBP2,Retinol-binding protein 2,Wald ratio,1,0.98 [0.88-1.09],0.727291004339047,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD14,Monocyte differentiation antigen CD14,Wald ratio,1,0.98 [0.88-1.09],0.728557985698669,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LGALS9,Galectin-9,Wald ratio,1,0.98 [0.89-1.08],0.730812626620585,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Wald ratio,1,0.98 [0.89-1.09],0.733286723417935,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NEFL,Neurofilament light polypeptide,Wald ratio,1,0.98 [0.89-1.08],0.736947660856718,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GFRA1,GDNF family receptor alpha-1,Wald ratio,1,1.02 [0.92-1.13],0.741081340530714,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FGFR2,Fibroblast growth factor receptor 2,Wald ratio,1,0.98 [0.89-1.09],0.741336549342719,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FGF5,Fibroblast growth factor 5,Wald ratio,1,0.98 [0.9-1.08],0.741661777326179,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADM,Pro-adrenomedullin,Wald ratio,1,0.98 [0.89-1.09],0.746603661749934,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.02 [0.91-1.13],0.754854745349631,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DSC2,Desmocollin-2,Wald ratio,1,0.98 [0.89-1.09],0.763845383085782,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,Wald ratio,1,1.02 [0.92-1.12],0.763969014678759,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.02 [0.92-1.13],0.767589176182201,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,0.98 [0.89-1.09],0.768620371206788,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NPDC1,Neural proliferation differentiation and control protein 1,Wald ratio,1,0.98 [0.89-1.09],0.769733149922921,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TFF2,Trefoil factor 2,Wald ratio,1,1.02 [0.91-1.13],0.770673351327663,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VSIG2,V-set and immunoglobulin domain-containing protein 2,Wald ratio,1,1.02 [0.91-1.13],0.772962725230815,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,AMBP,Protein AMBP,Wald ratio,1,0.98 [0.89-1.09],0.773545085039275,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EFNA1,Ephrin-A1,Wald ratio,1,0.98 [0.89-1.09],0.774470515853885,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CTHRC1,Collagen triple helix repeat-containing protein 1,Wald ratio,1,1.01 [0.92-1.12],0.775762511176856,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ATRAID,All-trans retinoic acid-induced differentiation factor,Wald ratio,1,1.02 [0.91-1.13],0.776750885675984,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HEPH,Hephaestin,Wald ratio,1,0.99 [0.89-1.1],0.793157599909043,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD160,CD160 antigen,Wald ratio,1,1.01 [0.91-1.13],0.794290020246926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Wald ratio,1,1.01 [0.91-1.13],0.794520655413426,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CX3CL1,Fractalkine,Wald ratio,1,0.99 [0.89-1.1],0.804353658001926,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SORCS2,VPS10 domain-containing receptor SorCS2,Wald ratio,1,0.99 [0.89-1.09],0.804932235141058,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD59,CD59 glycoprotein,Wald ratio,1,0.99 [0.89-1.09],0.808401974600634,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CTSB,Cathepsin B,Wald ratio,1,1.01 [0.92-1.12],0.809856172408968,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,THBD,Thrombomodulin,Wald ratio,1,0.99 [0.89-1.1],0.811953940760001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Wald ratio,1,0.99 [0.89-1.09],0.812083726123024,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,BOC,Brother of CDO,Wald ratio,1,0.99 [0.89-1.1],0.817853333751905,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Wald ratio,1,0.99 [0.89-1.1],0.818604264864192,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EFNA4,Ephrin-A4,Wald ratio,1,1.01 [0.91-1.13],0.829779975657222,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MUC13,Mucin-13,Wald ratio,1,0.99 [0.89-1.1],0.835893881597697,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Wald ratio,1,0.99 [0.89-1.1],0.840220896631407,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.99 [0.89-1.1],0.84852029350682,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HAVCR2,Hepatitis A virus cellular receptor 2,Wald ratio,1,0.99 [0.89-1.1],0.849170980608054,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD302,CD302 antigen,Wald ratio,1,0.99 [0.89-1.1],0.852542961822322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PIGR,Polymeric immunoglobulin receptor,Wald ratio,1,0.99 [0.89-1.1],0.855829028969644,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SCARB2,Lysosome membrane protein 2,Wald ratio,1,1.01 [0.91-1.12],0.86163586255177,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD27,CD27 antigen,Wald ratio,1,0.99 [0.89-1.1],0.863092699371396,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CHGA,Chromogranin-A,Wald ratio,1,0.99 [0.89-1.1],0.863618532862416,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,XG,Glycoprotein Xg,Wald ratio,1,1.01 [0.93-1.09],0.863781220455103,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SHISA5,Protein shisa-5,Wald ratio,1,1.01 [0.91-1.12],0.864141120239832,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CLMP,CXADR-like membrane protein,Wald ratio,1,0.99 [0.9-1.09],0.866760672850991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,KLK11,Kallikrein-11,Wald ratio,1,0.99 [0.89-1.1],0.871073763862773,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Wald ratio,1,0.99 [0.91-1.09],0.874410364654118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LAYN,Layilin,Wald ratio,1,1.01 [0.91-1.11],0.874888180424277,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ASGR1,Asialoglycoprotein receptor 1,Wald ratio,1,0.99 [0.89-1.1],0.875653966203448,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PRELP,Prolargin,Wald ratio,1,0.99 [0.9-1.09],0.875755558597855,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TFF1,Trefoil factor 1,Wald ratio,1,1.01 [0.91-1.12],0.881718469302001,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MAMDC2,MAM domain-containing protein 2,Wald ratio,1,0.99 [0.89-1.1],0.882447263852978,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.99 [0.9-1.1],0.883830011989185,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PKD1,Polycystin-1,Wald ratio,1,1.01 [0.91-1.11],0.88493803976607,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.99 [0.9-1.09],0.896580520687216,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SPINT2,Kunitz-type protease inhibitor 2,Wald ratio,1,0.99 [0.89-1.11],0.897653643110852,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,DPP6,Dipeptidyl aminopeptidase-like protein 6,Wald ratio,1,1.01 [0.91-1.12],0.897706160576373,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,OGN,Mimecan,Wald ratio,1,1.01 [0.92-1.1],0.900813710661322,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CLEC1A,C-type lectin domain family 1 member A,Wald ratio,1,0.99 [0.9-1.1],0.90127390013854,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,0.99 [0.89-1.1],0.901658753178911,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MDK,Midkine,Wald ratio,1,1.01 [0.9-1.12],0.902452036662124,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Wald ratio,1,1.01 [0.91-1.11],0.905252910596841,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,APOA4,Apolipoprotein A-IV,Wald ratio,1,0.99 [0.89-1.11],0.906389056742688,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ANGPT2,Angiopoietin-2,Wald ratio,1,0.99 [0.89-1.11],0.908967103222081,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGF1R,Insulin-like growth factor 1 receptor,Wald ratio,1,0.99 [0.9-1.1],0.909303283862922,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LY6D,Lymphocyte antigen 6D,Wald ratio,1,0.99 [0.9-1.1],0.912761128710438,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MMP7,Matrilysin,Wald ratio,1,1.01 [0.91-1.11],0.916063202333342,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LTBP2,Latent-transforming growth factor beta-binding protein 2,Wald ratio,1,1 [0.92-1.1],0.919391048490113,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SCARF2,Scavenger receptor class F member 2,Wald ratio,1,1 [0.92-1.1],0.921069657425637,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,HYOU1,Hypoxia up-regulated protein 1,Wald ratio,1,0.99 [0.89-1.11],0.92124444024394,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LIFR,Leukemia inhibitory factor receptor,Wald ratio,1,0.99 [0.89-1.11],0.92171876878798,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,VCAM1,Vascular cell adhesion protein 1,Wald ratio,1,0.99 [0.89-1.11],0.921928355423991,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ACVRL1,Serine/threonine-protein kinase receptor R3,Wald ratio,1,1.01 [0.91-1.11],0.922649514948291,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FABP3,"Fatty acid-binding protein, heart",Wald ratio,1,1 [0.9-1.1],0.927889135019118,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NRP1,Neuropilin-1,Wald ratio,1,1 [0.91-1.12],0.927903142821196,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IL18BP,Interleukin-18-binding protein,Wald ratio,1,1 [0.9-1.11],0.929577474239683,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Wald ratio,1,1 [0.9-1.12],0.930661884096494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,SMOC1,SPARC-related modular calcium-binding protein 1,Wald ratio,1,1 [0.9-1.1],0.942132555308243,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CA12,Carbonic anhydrase 12,Wald ratio,1,1 [0.9-1.11],0.94407250725515,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,WFDC2,WAP four-disulfide core domain protein 2,Wald ratio,1,1 [0.9-1.1],0.947341986890067,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,KLK4,Kallikrein-4,Wald ratio,1,1 [0.92-1.09],0.952095965680731,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,MFAP4,Microfibril-associated glycoprotein 4,Wald ratio,1,1 [0.9-1.12],0.956403754860415,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP3,Insulin-like growth factor-binding protein 3,Wald ratio,1,1 [0.91-1.11],0.956519003820086,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1 [0.91-1.11],0.961417224400989,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CD79B,B-cell antigen receptor complex-associated protein beta chain,Wald ratio,1,1 [0.9-1.11],0.964191134799932,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CALB1,Calbindin,Wald ratio,1,1 [0.9-1.11],0.972247261658494,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,JAM2,Junctional adhesion molecule B,Wald ratio,1,1 [0.9-1.11],0.974825170534298,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,IGFBP6,Insulin-like growth factor-binding protein 6,Wald ratio,1,1 [0.91-1.1],0.976429613519762,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Wald ratio,1,1 [0.91-1.1],0.978370244009546,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CXADR,Coxsackievirus and adenovirus receptor,Wald ratio,1,1 [0.9-1.11],0.980335776216352,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,PTK7,Inactive tyrosine-protein kinase 7,Wald ratio,1,1 [0.89-1.12],0.981617899343914,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,CXCL16,C-X-C motif chemokine 16,Wald ratio,1,1 [0.9-1.11],0.982198459835049,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,REG1A,Lithostathine-1-alpha,Wald ratio,1,1 [0.9-1.11],0.988233795889929,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,FSTL3,Follistatin-related protein 3,Wald ratio,1,1 [0.9-1.11],0.990108567867372,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,TGFBR2,TGF-beta receptor type-2,Wald ratio,1,1 [0.9-1.11],0.991588798223643,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,NPC2,NPC intracellular cholesterol transporter 2,Wald ratio,1,1 [0.9-1.11],0.994409113777781,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,GM2A,Ganglioside GM2 activator,Wald ratio,1,1 [0.91-1.1],0.996755755200904,trans
"Chapter IV Endocrine, nutritional and metabolic diseases",DM_NEUROPATHY,ADA2,Adenosine deaminase 2,Wald ratio,1,1 [0.9-1.11],0.997382835419578,trans
